Cited by 16Drug Solubulity and Delivery SystemsNanoparticle-Based Drug DeliveryCrystallization and Solubility Studies

Recent Trends in Nanocrystals for Pharmaceutical Applications

Sun, Leming, Hu, Yanzi, Zhang, Lianbing·2018·Current Pharmaceutical Design

Abstract

Background: As the quick development of modern methods and technologies currently, more and more drugs have been invented with a better efficiency. However, the poor water solubility has limited the drugs’ pharmaceutical application. Methods: Tremendous research has been put in the design and development of nanocrystals for pharmaceutical applications over the past few decades. The nanocrystals not only have the chance to solve the poor solubility problem, but also could conquer the bioavailability and even the specific delivery problems. The physical properties of drugs can be changed dramatically due to the change of their size in a nanodimension. Therefore, the nanocrystals have great potential to overcome the challenge to design and development of new drugs for pharmaceutical applications. Results: In this review, we provide an overview of the recent trends in nanocrystals for pharmaceutical applications. Conclusion: The current technologies including top-down, bottom-up, and combinative technologies for nanocrystals were fully examined. Most importantly, the emphasis is put on the pharmaceutical applications including their formulation, administration methods, safety, and toxicity. The commercial status, limitations, challenges, and future trends of the nanocrystals for pharmaceutical applications were also discussed.

Integrity signals

Registry

Crossref · 10.2174/1381612824666180524103341

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Smart nanoparticles for ratiometric delivery of synergistic drug combinations have many potential benefits in clinical applications for cancer treatment.

    “There are many potential benefits of using smart nanoparticles for ratio-metric delivery of synergistic drug combination for cancer treatment in clinical applications.332,333”

    From Smart nanoparticles for cancer therapy (2023) · cites this paper as [333]

Cited by

Sorted by citations

Authors
Sun, L., Hu, Y., & Zhang, L.
Affiliations
  • Northwestern Polytechnical University (CN)
  • Xi'an Shiyou University (CN)
Corresponding author
  • Sun, Leming
  • Zhang, Lianbing
Venue
Current Pharmaceutical Design
Published
2018-10-15
Volume
24
Issue
21
Pages
2394-2402
ISSN
1381-6128 (ISSN-L)
OpenAlex
W2804577318
Cited by
15
References
0
Citations by year
2025: 2 · 2024: 2 · 2023: 4 · 2022: 3 · 2021: 2 · 2020: 2
FWCI
0.47
Type
journal article
Language
en
Open access
closed
Locations
  • Current Pharmaceutical Design (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Physical Sciences › Materials Science › Materials Chemistry › Crystallization and Solubility Studies
Keywords
drug nanocrystals, poor water solubility, bioavailability, drug delivery, administration methods, pharmaceutical applications
MeSH terms
Pharmaceutical Preparations, Humans, Technology, Pharmaceutical, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review